Pembrolizumab as first-line treatment for kidney cancer
The recent phase II KEYNOTE-427 study investigated the efficacy and [...]
The impact of sex and age on distribution of metastases in patients with kidney cancer
A recent study published in the International Journal of Clinical [...]
Effect of antibiotics on outcomes with systemic treatments for metastatic kidney cancer
The microbes in the gut (the gut microbiome) are a [...]
Warning over COVID-19 cons
The NHS has teamed up with the police and security [...]
What to expect: Enrolling on a cancer clinical trial during the COVID-19 pandemic
The COVID-19 pandemic has resulted in a number of changes [...]
Cabozantinib plus nivolumab granted FDA approval for first-line treatment of advanced kidney cancer
The Food and Drug Administration (FDA) in the United States has [...]
Delay in surgery and overall survival in patients with T2 renal masses
In a recent study of 11,848 patients who had surgery [...]
Past COVID-19 infection provides some immunity but people may still transmit the virus
A Public Health England (PHE) study (SIREN) finds past infection [...]
Obesity diminishes response to immunotherapy in kidney cancer
In this study, the researchers looked at the interaction between [...]
Obesity and kidney cancer
A large review of the data showed that cancer specific [...]
